Moxonidine Generics [uk] (Moxonidine)

Moxonidine selectively activates imidazoline I1 receptors in the brainstem. This activation reduces sympathetic outflow, leading to decreased peripheral resistance and a modest reduction in cardiac output, which together lower arterial blood pressure.

The dosage of Moxonidine is individualized by the prescribing clinician based on the patient’s blood‑pressure profile, age, renal function and concomitant therapies. No fixed regimen is provided here.

Safety data for Moxonidine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk, and a healthcare professional should be consulted before starting therapy.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Moxonidine belongs to the central‑acting imidazoline agonist class, differing from ACE inhibitors, ARBs or calcium‑channel blockers. It primarily reduces sympathetic tone, whereas other classes act on the renin‑angiotensin system or vascular smooth‑muscle calcium channels. Choice depends on patient profile and tolerability.

Store Moxonidine tablets at room temperature, below 25 °C, in the original blister pack or container. Protect from moisture and direct sunlight to maintain stability.

Moxonidine is taken orally, usually with a glass of water. It can be taken with or without food, but consistency with meals may help reduce gastrointestinal discomfort.

Serious adverse events include severe hypotension, bradycardia, allergic reactions such as rash or anaphylaxis, hepatic dysfunction, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat, or signs of an allergic reaction.

Moxonidine is contraindicated in patients with known hypersensitivity to the drug, severe bradycardia, or those who are pregnant without specialist advice. Caution is also advised for individuals with significant liver disease or uncontrolled heart failure.